A Phase II Clinical Study for Evaluating the Efficacy and Safety of Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone in Transplantation-Eligible Elderly Patients with Newly Diagnosed Multiple Myeloma (KMM2101)
- Authors
- Yoon, Sang Eun; Jung, Sung-Hoon; Lee, Gyeong Won; Min, Chang-Ki; Byun, Ja Min; Kwak, Jae-Yong; Lee, Myung-Won; Lee, Ho Sup; Kim, Seok Jin; Kim, Kihyun
- Issue Date
- Nov-2024
- Publisher
- ELSEVIER
- Citation
- BLOOD, v.144, pp 7045 - 7046
- Pages
- 2
- Indexed
- SCIE
SCOPUS
- Journal Title
- BLOOD
- Volume
- 144
- Start Page
- 7045
- End Page
- 7046
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/77185
- DOI
- 10.1182/blood-2024-198947
- ISSN
- 0006-4971
1528-0020
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.